- CEO
- Masanori Hoshino
- Full Time Employees
- 2,892
- Sector
- Consumer services
- Industry
- Restaurants
- Address
- 10-11 Sarugakucho Tokyo TY Japan 150-0033
- IPO Date
- Oct 1, 2007
- Business
- DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) operates as a Japan-based holding company primarily engaged in the roasting, processing, and sale of coffee, as well as the operation and management of coffee shops, restaurants, and related food service businesses. The company offers a diverse portfolio of products and services through its two main segments: the Doutor Cafe Group, which manages coffee chains via directly managed stores and franchise systems, including the procurement, roasting, processing, and sale of coffee beans; and the Japan Restaurant System Group, which oversees restaurant chains, bakery production and sales including breads, pastries, confectionery products, hams, sausages, bacons, sauces, dressings, and foodstuffs such as fruits, vegetables, and meats. Additional operations encompass the manufacture and wholesale of coffee machines, import and export of food items, store design, construction, maintenance, cleaning services, and natural food stores, primarily targeting consumers in Japan under various brands specializing in Italian coffee and sandwiches, pasta, American food, Hawaiian coffee, Asian noodles, barbecue, donuts via the Nichires chain, candy, cheesecake, egg products, tea, and health foods.
Founded in 2007 through the establishment of a joint holding company and headquartered at 10-11 Sarugaku-cho, Shibuya-ku, Tokyo, Japan, the company traces its origins to Doutor Coffee established in 1962 and has grown via strategic acquisitions and organic expansion into a diversified food and beverage entity with approximately 2,767 employees and nearly two dozen subsidiaries managing franchise chains.
Recent developments include ongoing treasury share repurchases, with notices issued in July 2025 regarding status and completion, alongside multiple executions in June, May, and earlier periods; director changes announced in April 2025 and May 2025 for group companies; and restricted stock compensation disposals in May 2025. The company released its fiscal year 2025 financial results in April 2025, reporting revenue growth to approximately 151 billion yen, alongside interim and quarterly supplements through November 2025 demonstrating sustained segment performance in Doutor Coffee (89.1 billion yen) and Japanese Restaurant System (55.29 billion yen), with dividend adjustments upward in multiple periods including July 2025.